A long standing study found that taking common headache pill can diminish the risk of wide series of cancers. The previous studies revealed that high dose of drug could lower the risk. However, the latest study shows that low dose of aspirin over longer period can diminish risk of colon and rectal cancer by twenty percent.
The long term use of aspirin can diminish the risk of gastrointestinal cancer up to thirty-five percent. The research team from Oxford, London, Edinburgh and Japan analyzed aspirin trails on heart attacks and strokes carried out between 1980 and 1990. They examined if there was variation in rates of cancer twenty and thirty years on.
According to study leader Professor Peter Rothwell from Oxford University they initially observed some of the high dose aspirin trials and showed that aspirin certainly prevented colon and rectal cancer. The statistics proposes a lasting benefit of taking aspirin. People who had taken aspirin for a period had twenty percent lesser risk of death from certain types of cancer.
Some earlier statistics suggested that aspirin might have an effect on the growth of cancers in lab cell cultures and in animal models of cancer. There was also some sustaining observational statistics in humans. The trail of aspirin in observing heart attacks and strokes showed little benefits in preventing both, stated Prof Rothwell.
These benefits were partly counteracted by the risk of stomach bleeding, but there are still some advantages. When you add in the cancer benefit on top of that it pushes things much more in favour, reported the study published in The Lancet.